- Home
- / Shanghai Shenlian Biomedical
Shanghai Shenlian Biomedical
Stock Price
¥5
2024-10-29
Market Capitalization
¥2 B
2024-10-29
Revenue
¥297.6 M
FY, 2024
Shanghai Shenlian Biomedical Summary
Company Summary
- Overview
- Shanghai Shenlian Biomedical is a company that produces veterinary biological products. It offers bivalent inactivated and synthetic peptide vaccines, and other products for foot and mouth disease.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- CN | view all locations
- Website
- http://www.slbio.com.cn
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Shang Hai Shi HQ
China
Jiang Chuan Dong Lu, Min Hang Qu
Shanghai Shenlian Biomedical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥61.2M
- Gross profit (Q1, 2026)
- ¥38.2M
- Net income (Q1, 2026)
- (¥2.4M)
- Cash (Q1, 2026)
- ¥72.8M
- EBIT (Q1, 2026)
- (¥2.6M)
- Enterprise value
- $2.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026